中文 | English
Return
Total: 217 , 1/22
Show Home Prev Next End page: GO
Author:(Wen-De HONG)

1.Synthesis of active substance 3,4-dihydroxyacetophenone from traditional Chinese medicine using Escherichia coli whole-cell bioconversion of 1-(4-hydroxyphenol)-ethanol.

Xi-Wei YUAN ; Yan-Qiu TIAN ; Wen-Yu WANG ; Ya-Lun ZHANG ; De-Hong XU

China Journal of Chinese Materia Medica 2025;50(5):1187-1194

2.Processing technology of calcined Magnetitum based on concept of QbD and its XRD characteristic spectra.

De-Wen ZENG ; Jing-Wei ZHOU ; Tian-Xing HE ; Yu-Mei CHEN ; Huan-Huan XU ; Jian FENG ; Yue YANG ; Xin CHEN ; Jia-Liang ZOU ; Lin CHEN ; Hong-Ping CHEN ; Shi-Lin CHEN ; Yuan HU ; You-Ping LIU

China Journal of Chinese Materia Medica 2025;50(9):2391-2403

3.Optimization of extraction process for Shenxiong Huanglian Jiedu Granules based on AHP-CRITIC hybrid weighting method, grey correlation analysis, and BP-ANN.

Zi-An LI ; De-Wen LIU ; Xin-Jian LI ; Bing-Yu WU ; Qun LAN ; Meng-Jia GUO ; Jia-Hui SUN ; Nan-Yang LIU ; Hui PEI ; Hao LI ; Hong YI ; Jin-Yu WANG ; Liang-Mian CHEN

China Journal of Chinese Materia Medica 2025;50(10):2674-2683

4.Progress on Wastewater-based Epidemiology in China: Implementation Challenges and Opportunities in Public Health.

Qiu da ZHENG ; Xia Lu LIN ; Ying Sheng HE ; Zhe WANG ; Peng DU ; Xi Qing LI ; Yuan REN ; De Gao WANG ; Lu Hong WEN ; Ze Yang ZHAO ; Jianfa GAO ; Phong K THAI

Biomedical and Environmental Sciences 2025;38(11):1354-1358

5.In vitro anti-tumor activities and mechanisms of phenothiazines in combined treatment with temozolomide in human glioma cell lines

Xin WEN ; De-ming ZHAO ; Fei-hong CHEN

Acta Pharmaceutica Sinica 2024;59(4):918-929

6.Clinical characteristics and nutritional status of children with Crohn's disease and risk factors for malnutrition

Dong-Dan LI ; Xiao-Lin YE ; Mei-Chen WANG ; Hong-Mei HUANG ; Jie YAN ; Tian-Zhuo ZHANG ; Fei-Hong YU ; De-Xiu GUAN ; Wen-Li YANG ; Lu-Lu XIA ; Jie WU

Chinese Journal of Contemporary Pediatrics 2024;26(11):1194-1201

7.Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients

Man-Fung YUEN ; Wan-Long CHUANG ; Cheng-Yuan PENG ; Wen-Juei JENG ; Wei-Wen SU ; Ting-Tsung CHANG ; Chi-Yi CHEN ; Yao-Chun HSU ; Guy DE LA ROSA ; Alaa AHMAD ; Ed LUO ; Annie L. CONERY

Clinical and Molecular Hepatology 2024;30(3):375-387

8.Antimicrobial resistance of bacteria from pleural and peritoneal effusion:surveillance report from Hunan Provincial Antimicrobial Resistance Sys-tem,2012-2021

Yong-Xue TANG ; Si-Yu WANG ; Xiao-Bing XIE ; Li-Hua CHEN ; Chen-Chao FU ; Chen LI ; Yan-Ming LI ; Jun LIU ; Nan REN ; Guo-Min SHI ; Jing-Min WU ; Huai-De YANG ; Hong-Xia YUAN ; Ming ZHENG ; Xun HUANG ; An-Hua WU ; Xing-Wang NING ; Xi-Mao WEN

Chinese Journal of Infection Control 2023;22(12):1438-1451

9.Antimicrobial susceptibility of Gram-positive organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3509-3524

10.Antimicrobial susceptibility of Gram-negative organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3525-3544

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 217 , 1/22 Show Home Prev Next End page: GO